Johnson & Johnson softens FDA’s Invokana blow with positive kidney resultsAllbiopro2018-07-18T09:30:56+09:007월 18th, 2018|
Janssen Halts Phase III Kidney Disease Trial Early after Endpoints Were MetAllbiopro2018-07-18T09:30:00+09:007월 18th, 2018|
Janssen Announces U.S. FDA Approval of SYMTUZA™ (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 InfectionAllbiopro2018-07-18T09:29:05+09:007월 18th, 2018|
Inozyme Pharma Receives Orphan Drug Designation for INZ-701 in the United States and European UnionAllbiopro2018-07-18T09:28:07+09:007월 18th, 2018|
HotSpot Therapeutics Emerges From Stealth Mode With $45 Million to Aim at New Biological TargetsAllbiopro2018-07-18T09:26:23+09:007월 18th, 2018|
For 2 biotech employees, coming out as trans means asking others to transition with themAllbiopro2018-07-18T09:25:12+09:007월 18th, 2018|
FDA Clears First Nanotechnology Peek Devices for Spinal Intervertebral FusionAllbiopro2018-07-18T09:24:42+09:007월 18th, 2018|
Eisai Inc. Announces Positive Topline Results from CAMELLIA-TIMI 61, a Large-Scale Cardiovascular Outcome Trial for the Anti-Obesity Agent BELVIQ®Allbiopro2018-07-18T09:23:46+09:007월 18th, 2018|
Difficult Q4 for Avid as it Pushes to Diversify Customers and Fill CapacityAllbiopro2018-07-18T09:22:47+09:007월 18th, 2018|
Could Amgen Eye Alexion as a M&A Target to Offset Neulasta Decline?Allbiopro2018-07-18T09:21:50+09:007월 18th, 2018|
Celgene, Takeda invest in intratumoral microdosing firm PresageAllbiopro2018-07-18T09:20:55+09:007월 18th, 2018|
Bristol-Myers Squibb to lay off 149 as Wallingford, Connecticut, site nears closureAllbiopro2018-07-18T09:19:06+09:007월 18th, 2018|
Blade Therapeutics Announces Initiation of Phase 1 Study of Lead Calpain Inhibitor BLD-2660 for FibrosisAllbiopro2018-07-18T09:18:10+09:007월 18th, 2018|
Ascentage third round garners $150M for apoptosis cancer drugsAllbiopro2018-07-18T09:17:13+09:007월 18th, 2018|
